United Kingdom's drug regulator on Friday informed that it had approved the <a href="https://www.mid-day.com/news/india-news/article/visas-of-stranded-foreign-nationals-extended-till-august-31-free-of-charge-mha-23176658" target="_blank" rel="noopener">Covid-19 </a>vaccine developed by Pfizer and BioNTech for use on 12 to 15 year-olds after similar clearances were given in the US and the EU.
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) today announced this decision following a "rigorous review" of the safety, and effectiveness of the vaccine in this age group.
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the <a href="https://www.mid-day.com/news/india-news/article/govt-holding-discussions-with-pfizer-johnson-johnson-mos-g-kishan-reddy---23176354" target="_blank" rel="noopener">Pfizer</a>/BioNTech Covid-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," said Dr June Raine, MHRA Chief Executive.
Also Read: <a href="https://www.mid-day.com/news/world-news/article/pfizer-jab-produces-less-antibodies-against-delta-variant-of-coronavirus-lancet-study-23176644" target="_blank" rel="noopener">Pfizer jab produces less antibodies against Delta variant of coronavirus: Lancet study</a>
"We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved COVID-19 vaccines and this surveillance will include the 12- to 15-year age group," Dr Raine added.
The Pfizer/BioNTech Covid-19 vaccine is already approved for use in adults and adolescents aged 16 years and above.
Professor Sir Munir Pirmohamed, Chair of the Commission on Human Medicines said: "Over 2,000 children aged 12-15 years were studied as part of the randomised, placebo-controlled clinical trials. There were no cases of COVID-19 from 7 days after the second dose in the vaccinated group, compared with 16 cases in the placebo group."
This approval of Pfizer/BioNTech comes as the administration of the vaccine to younger people in rich countries has garnered criticism from World Health Organisation (WHO). WHO has urged rich countries to give shots to the COVAX initiative.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

Britain`s Medicines and Healthcare products Regulatory Agency (MHRA) today announced this decision following a "rigorous review" of the safety, and effectiveness of the vaccine in this age group

UK approves Pfizer/ BioNTech Covid-19 shot for 12 to 15-year-olds

Pfizer jab produces less antibodies against Delta variant: Lancet study

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) today announced this decision following a "rigorous review" of the safety, and effectiveness of the vaccine in this age group

UK approves Pfizer/ BioNTech Covid-19 shot for 12 to 15-year-olds

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast

Home / News / World News / Article / UK approves Pfizer/ BioNTech Covid-19 shot for 12 to 15-year-olds

UK approves Pfizer/ BioNTech Covid-19 shot for 12 to 15-year-olds

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast